Sinapine hydroxide exhibits anti-inflammatory, antioxidant, antitumor, anti-angiogenic, and radioprotective activities; it acts as an acetylcholinesterase (AChE) inhibitor and is used in the study of Alzheimer's disease, ataxia, myasthenia gravis, and Parkinson's disease; it counteracts mitochondrial oxidative stress in cardiomyocytes; inhibits proliferation of Caco-2 cells in a dose-dependent manner with relatively low toxicity; enhances doxorubicin accumulation in Caco-2 cells by downregulating P-glycoprotein (P-gp); significantly reduces phosphorylation of FRS2α and ERK1/2; and ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota composition.